HR8764Referred to Committee

TREAT PTSD TRICARE Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-05-12
Introduced
0
Cosponsors
HR
Type

Sponsor

Scott Perry
Scott Perry
Republican · PA · Representative
Votes with party: 86.4% (595 recorded votes)
Top industries funding sponsor:
  • Conservative Groups$2,079k

Full profile: /officials/P000605

Source: Congress.gov · FEC

Cosponsors (0)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Armed Services.

2026-05-12

Source: Congress.gov

Committee Activity

Currently in

Plain-English Summary

The proposal would require the Department of Defense to offer stellate ganglion block (a nerve-blocking injection treatment) to military members diagnosed with post-traumatic stress disorder as a treatment option. This medical procedure, which targets nerves in the neck area to reduce stress responses, would be made available to active-duty service members and veterans dealing with PTSD symptoms. The bill aims to expand treatment options for military personnel struggling with trauma-related mental health conditions.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Armed Forces and National Security

Full Bill Text

Verbatim text published on Congress.gov via GovInfo. Use Cmd+F / Ctrl+F to search within this excerpt.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 8764 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 8764 To direct the Secretary of Defense to furnish stellate ganglion block to members of the Armed Forces with post-traumatic stress disorder, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES May 12, 2026 Mr. Perry introduced the following bill; which was referred to the Committee on Armed Services _______________________________________________________________________ A BILL To direct the Secretary of Defense to furnish stellate ganglion block to members of the Armed Forces with post-traumatic stress disorder, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Treatment and Relief through Emerging and Accessible Therapy for PTSD TRICARE Act'' or the ``TREAT PTSD TRICARE Act''. SEC. 2. PROVISION OF STELLATE GANGLION BLOCK TO MEMBERS OF THE ARMED FORCES WITH POST-TRAUMATIC STRESS DISORDER. (a) Provision to Members of the Armed Forces.-- (1) In general.--Chapter 55 of title 10, United States Code, is amended by inserting after section 1074o the following new section: ``Sec. 1074p. Provision of stellate ganglion block for certain members ``(a) In General.--The Secretary shall furnish stellate ganglion block to any member of the Armed Forces (including the reserve components) who is performing or has performed active service and who-- ``(1) is enrolled in the TRICARE program under chapter 55 of this title; ``(2) has been diagnosed with post-traumatic stress disorder; and ``(3) has elected to receive stellate ganglion block after being informed by a qualified health care provider of the risks and benefits of stellate ganglion block. ``(b) Provision of Care.--The Secretary may furnish stellate ganglion block under subsection (a) through a medical facility of the Department or through a qualified health care provider participating in a Department administered TRICARE health insurance program.''. (2) Clerical amendment.--The table of contents at the beginning of chapter 55 of title 10, United States Code, is amended by inserting after the item relating to section 1074o the following new item: ``1074p. Provision of stellate ganglion block for certain members.''. (b) Update of Joint Clinical Practice Guideline.-- (1) Update of guideline.--Not later than 180 days after the date of the enactment of this Act, the Secretary of Defense shall update the guideline titled the ``VA/DOD Clinical Practice Guideline (CPG) for the Management of PTSD'' (or such successor guideline) to ensure the guideline-- (A) reflects the availability of stellate ganglion block as a therapy option; and (B) includes information on the clinical indicators and contraindicators for such therapy option. (2) Notification.--Upon updating the guideline under paragraph (1), the Secretary shall notify the congressional defense committees (as such term is defined in section 101 of title 10, United States Code) of such update. (c) Effective Date.--The amendment made by subsection (a) shall take effect on the date that is 180 days after the date of the enactment of this Act. <all>

Related legislation

Bills by the same sponsor or covering overlapping subjects.